Johnson G F, Hunt G E, Duggin G G, Horvath J S, Tiller D J
J Affect Disord. 1984 Jun;6(3-4):249-63. doi: 10.1016/s0165-0327(84)80003-8.
Assessment of renal function was carried out in an unselected sample of patients with bipolar manic-depressive disorder receiving lithium for an average period of 4.5 years. Overall, glomerular filtration rate (GFR) fell within the established normal range based on sex and age, whereas measures of urinary concentrating ability were generally impaired. There was no relationship between duration of lithium treatment and either GFR or impairment of urinary concentrating ability. Moreover, there was no evidence of a progressive impairment of glomerular or tubular function in patients re-tested after 2 years. The results of this study confirm the safety of lithium administration in the majority of patients and emphasize the importance of careful clinical monitoring to avoid lithium intoxication.
对未经过挑选的双相躁狂抑郁症患者样本进行了肾功能评估,这些患者平均服用锂盐4.5年。总体而言,基于性别和年龄,肾小球滤过率(GFR)落在既定的正常范围内,而尿浓缩能力的指标普遍受损。锂盐治疗时长与GFR或尿浓缩能力受损之间均无关联。此外,在2年后重新接受检测的患者中,没有证据表明肾小球或肾小管功能出现进行性损害。这项研究的结果证实了在大多数患者中给予锂盐治疗的安全性,并强调了进行仔细临床监测以避免锂中毒的重要性。